samedan logo
 
 
spacer
home > pmps > summer 2008 > special dispensation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Special Dispensation

Pressure is increasing on today’s pharmaceutical industry to implement more reliable and consistent safeguards against mistakes in dispensing medication, whether from contamination, mixing up drugs or inappropriate dosing. As a result, pharmaceutical companies are turning to non-destructive testing (NDT) techniques for product and packaging inspection.

A number of these techniques have already been adopted, including the use of optical, infra-red, ultrasound, vacuum decay and x-ray inspection methods. Traditionally, these have primarily been used for batch control through various batch sampling and inspection strategies. However, there is increasing demand for in-line inspection of all products, particularly where they have high commercial value or involve high dosage levels.

Applications for in-line NDT of products are as varied as the products themselves. Typical inspection scenarios may entail: checking fill levels in bottles and tubs of drugs, in liquid, powder, and even tablet forms; checking for missing tablets in blister packs; detecting contaminants (such as metal or glass) in dressings; and checking for correctly assembled devices.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Martin Allen graduated from Nottingham University with an Honours Degree in Geology in 1989 and gained a Doctorate in Engineering in 1993, specialising in image processing and analysis. After two years of developing an advanced document imaging system, Martin joined the software department of OIS Engineering in 1996. Some 11 years later, OIS has become Shaw Inspection Systems, and Martin has become a leading expert in both digital radiography (DR), and computed tomography (CT). He now heads the software department and is responsible for current research and development into both DR and CT.
spacer
Martin Allen
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

DIA 4th Annual Clinical Forum & Exhibition

11-13 October 2010, Lisbon, Portugal

The DIA 4th Annual Clinical Forum provides access to sessions covering nine multidisciplinary themes, including Clinical Data Management/eClinical, Clinical Operations, Clinical Research, Peri- and Post Approval Studies, Drug Safety and Risk Management, Quality Assurance, Clinical Endpoints, e-Technology and Validation and Medical Information & Communications.
More info >>

 
News and Press Releases

Glycotope GMBH

Berlin, Germany – August 4, 2010 Glycotope GmbH, a leading glycobiology company, has received regulatory approval by German and Italian regulatory authorities for a Phase I study of Glycotope´s next generation antibody CetuGEX (GT-MAB 5.2-GEX) for the treatment of various solid cancers.
More info >>

 

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement